WAL vs. CVS
WAL (Western Alliance Bancorporation) and CVS (CVS Health Corporation) are both stocks. WAL operates in Banks - Regional (Financial Services), while CVS operates in Healthcare Plans (Healthcare). Over the past 10 years, WAL returned 9.17%/yr vs 2.58%/yr for CVS. At a 0.32 correlation, their price movements are largely independent.
Performance
WAL vs. CVS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, WAL achieves a -6.57% return, which is significantly lower than CVS's 17.10% return. Over the past 10 years, WAL has outperformed CVS with an annualized return of 9.17%, while CVS has yielded a comparatively lower 2.58% annualized return.
WAL
- 1D
- -3.05%
- 1M
- -2.08%
- YTD
- -6.57%
- 6M
- -7.49%
- 1Y
- 8.33%
- 3Y*
- 29.77%
- 5Y*
- -3.29%
- 10Y*
- 9.17%
CVS
- 1D
- 2.09%
- 1M
- 11.41%
- YTD
- 17.10%
- 6M
- 23.91%
- 1Y
- 48.94%
- 3Y*
- 13.62%
- 5Y*
- 4.52%
- 10Y*
- 2.58%
WAL vs. CVS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
WAL Western Alliance Bancorporation | -6.57% | 2.55% | 29.67% | 14.12% | -43.68% | 81.72% | 7.77% | 45.90% | -30.25% | 16.24% |
CVS CVS Health Corporation | 17.10% | 84.35% | -40.77% | -12.53% | -7.63% | 54.87% | -5.14% | 17.26% | -7.04% | -5.75% |
Correlation
The correlation between WAL and CVS is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.06 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.23 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.27 |
Correlation (All Time) Calculated using the full available price history since Jul 5, 2005 | 0.32 |
Over the past year, the correlation between WAL and CVS has dropped to 0.06 - well below their long-term average of 0.32, suggesting their price drivers have been diverging.
Fundamentals
WAL:
$11.59
CVS:
$2.30
WAL:
6.71
CVS:
39.69
WAL:
1.21
CVS:
0.29
WAL:
$5.28B
CVS:
$407.91B
WAL:
$2.51B
CVS:
$56.59B
WAL:
$1.03B
CVS:
$9.99B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
WAL vs. CVS — Risk / Return Rank
WAL
CVS
WAL vs. CVS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Western Alliance Bancorporation (WAL) and CVS Health Corporation (CVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| WAL | CVS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.37 | ||
| Sortino ratioReturn per unit of downside risk | -1.48 | ||
| Omega ratioGain probability vs. loss probability | 1.07 | 1.31 | -0.23 |
| Calmar ratioReturn relative to maximum drawdown | 0.28 | 2.99 | -2.71 |
| Martin ratioReturn relative to average drawdown | 0.66 | 7.71 | -7.05 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| WAL | CVS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.22 | 1.60 | -1.37 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.05 | 0.15 | -0.21 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.18 | 0.09 | +0.09 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.11 | 0.33 | -0.22 |
Drawdowns
WAL vs. CVS - Drawdown Comparison
The maximum WAL drawdown since its inception was -92.14%, which is greater than CVS's maximum drawdown of -64.07%. Use the drawdown chart below to compare losses from any high point for WAL and CVS.
Loading charts...
Drawdown Indicators
| WAL | CVS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -92.14% | -64.07% | -28.07% |
Max Drawdown (1Y)Largest decline over 1 year | -30.26% | -16.44% | -13.82% |
Max Drawdown (3Y)Largest decline over 3 years | -35.98% | -43.98% | +8.00% |
Max Drawdown (5Y)Largest decline over 5 years | -84.79% | -56.79% | -28.00% |
Max Drawdown (10Y)Largest decline over 10 years | -84.79% | -56.79% | -28.00% |
Current DrawdownCurrent decline from peak | -29.78% | -6.87% | -22.91% |
Average DrawdownAverage peak-to-trough decline | -38.51% | -19.56% | -18.95% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.73% | 6.37% | +6.36% |
Volatility
WAL vs. CVS - Volatility Comparison
Western Alliance Bancorporation (WAL) and CVS Health Corporation (CVS) have volatilities of 10.54% and 11.02%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| WAL | CVS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.54% | 11.02% | -0.48% |
Volatility (6M)Calculated over the trailing 6-month period | 26.82% | 26.04% | +0.78% |
Volatility (1Y)Calculated over the trailing 1-year period | 37.52% | 30.79% | +6.73% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 60.28% | 29.91% | +30.37% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 52.30% | 29.28% | +23.02% |
Dividends
WAL vs. CVS - Dividend Comparison
WAL's dividend yield for the trailing twelve months is around 2.11%, less than CVS's 2.91% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CVS CVS Health Corporation | 2.91% | 3.35% | 5.93% | 3.06% | 2.36% | 1.94% | 2.93% | 2.69% | 3.05% | 2.76% | 2.15% | 1.43% |
WAL Western Alliance Bancorporation | 2.11% | 1.86% | 1.78% | 2.20% | 2.38% | 1.11% | 1.67% | 0.88% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
WAL vs. CVS - Financials Comparison
This section allows you to compare key financial metrics between Western Alliance Bancorporation and CVS Health Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
WAL vs. CVS - Profitability Comparison
WAL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Western Alliance Bancorporation reported a gross profit of 0.00 and revenue of 1.19B. Therefore, the gross margin over that period was 0.0%.
CVS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, CVS Health Corporation reported a gross profit of 15.62B and revenue of 100.43B. Therefore, the gross margin over that period was 15.6%.
WAL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Western Alliance Bancorporation reported an operating income of 0.00 and revenue of 1.19B, resulting in an operating margin of 0.0%.
CVS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, CVS Health Corporation reported an operating income of 4.68B and revenue of 100.43B, resulting in an operating margin of 4.7%.
WAL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Western Alliance Bancorporation reported a net income of 182.10M and revenue of 1.19B, resulting in a net margin of 15.3%.
CVS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, CVS Health Corporation reported a net income of 2.94B and revenue of 100.43B, resulting in a net margin of 2.9%.
Frequently Asked Questions
WAL and CVS have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CVS has higher volatility (11.02%) compared to WAL (10.54%). In terms of maximum drawdown, WAL dropped -92.14% vs CVS's -64.07%.
CVS currently has the higher Sharpe Ratio (1.60 vs 0.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for WAL and CVS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer